NeoCore Technology Co., Ltd. (4131.TWO)

TWD 36.3

(10.0%)

Market Cap (In TWD)

1.43 Billion

Revenue (In TWD)

64.72 Million

Net Income (In TWD)

-64.64 Million

Avg. Volume

62.98 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
22.0-40.5
PE
-
EPS
-
Beta Value
0.234
ISIN
TW0004131008
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Jack Lee
Employee Count
-
Website
https://www.bio-drchip.com.tw
Ipo Date
2007-12-31
Details
NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company's products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers laboratory planning, design, and other services. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and changed its name to NeoCore Technology Co., Ltd. in July 2023. NeoCore Technology Co., Ltd. was founded in 1987 and is headquartered in Tainan, Taiwan.